ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma
Cancer Immunology Immunotherapy
◽
10.1007/s002620050393
◽
1997
◽
Vol 44
(6)
◽
pp. 348-351
◽
Cited By ~ 6
Author(s):
A. Piga
◽
Paolo Giordani
◽
Agata Quattrone
◽
Marco Giulioni
◽
Giorgio De Signoribus
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Renal Cell
◽
Low Dose
◽
Phase Ii Study
◽
Interleukin 2
◽
Advanced Renal Cell Carcinoma
◽
Interferon Α
Download Full-text
Related Documents
Cited By
References
Subcutaneous Recombinant Interleukin-2 and a-Interferon in Patients with Advanced Renal Cell Carcinoma: Results of a Multicenter Phase II Study
Cancer Biotherapy
◽
10.1089/cbr.1993.8.289
◽
1993
◽
Vol 8
(4)
◽
pp. 289-300
◽
Cited By ~ 9
Author(s):
Jens Atzpodien
◽
Hartmut Kirchner
◽
Peter de Mulder
◽
Heiner Bodenstein
◽
Tim Olivera
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Renal Cell
◽
Phase Ii Study
◽
Interleukin 2
◽
Advanced Renal Cell Carcinoma
◽
Multicenter Phase
◽
Recombinant Interleukin 2
Download Full-text
Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study
British Journal of Cancer
◽
10.1054/bjoc.1999.0997
◽
2000
◽
Vol 82
(4)
◽
pp. 772-776
◽
Cited By ~ 40
Author(s):
C M L van Herpen
◽
R L H Jansen
◽
W H J Kruit
◽
K Hoekman
◽
G Groenewegen
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase Ii Study
◽
Interleukin 2
◽
Interferon Α
◽
Multicenter Phase
Download Full-text
Interleukin-2 (IL-2), interferon-α (IFN- α), 5-fluorouracil (5-FU) and vinblastine (VBL) for treatment of metastatic renal cell carcinoma (MRCC). A prospective phase II study
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.90140.4671
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 4671-4671
Author(s):
R. Rubinov
◽
E. Gez
◽
N. Haim
◽
A. Kuten
◽
S. Meritick
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase Ii Study
◽
Interleukin 2
◽
Interferon Α
◽
Prospective Phase
Download Full-text
Correlation of immune responses with survival in a randomized phase II study investigating multipeptide vaccination with IMA901 plus or minus low-dose cyclophosphamide in advanced renal cell carcinoma (RCC).
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.2587
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 2587-2587
◽
Cited By ~ 2
Author(s):
H. Singh
◽
N. Hilf
◽
R. Mendrzyk
◽
D. Maurer
◽
T. Weinschenk
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Immune Responses
◽
Cell Carcinoma
◽
Phase Ii
◽
Renal Cell
◽
Low Dose
◽
Phase Ii Study
◽
Advanced Renal Cell Carcinoma
◽
Randomized Phase Ii
Download Full-text
Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma
Annals of Oncology
◽
10.1093/oxfordjournals.annonc.a058626
◽
1993
◽
Vol 4
(8)
◽
pp. 689-691
◽
Cited By ~ 8
Author(s):
M. Lopez
◽
S. Carpano
◽
A. Cancrini
◽
M. Marcellini
◽
P. Del Medico
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Intravenous Infusion
◽
Renal Cell
◽
Phase Ii Study
◽
Interleukin 2
◽
Advanced Renal Cell Carcinoma
◽
Continuous Intravenous Infusion
◽
Recombinant Interleukin 2
Download Full-text
Interleukin-2 (IL-2), interferon-α (IFN- α), 5-fluorouracil (5-FU) and vinblastine (VBL) for treatment of metastatic renal cell carcinoma (MRCC). A prospective phase II study
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.4671
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 4671-4671
Author(s):
R. Rubinov
◽
E. Gez
◽
N. Haim
◽
A. Kuten
◽
S. Meritick
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase Ii Study
◽
Interleukin 2
◽
Interferon Α
◽
Prospective Phase
Download Full-text
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study
Annals of Oncology
◽
10.1093/annonc/mdf049
◽
2002
◽
Vol 13
(3)
◽
pp. 441-449
◽
Cited By ~ 18
Author(s):
F. Donskov
◽
H. von der Maase
◽
R. Henriksson
◽
U. Stierner
◽
P. Wersäll
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Outpatient Treatment
◽
Renal Cell
◽
Phase Ii Study
◽
Interleukin 2
◽
Interferon Α
◽
Histamine Dihydrochloride
◽
Multicentre Phase
Download Full-text
A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma
Cancer Immunology Immunotherapy
◽
10.1007/bf00205237
◽
1989
◽
Vol 28
(4)
◽
Cited By ~ 31
Author(s):
Albrecht Lindemann
◽
Klaus H�ffken
◽
ReinholdE. Schmidt
◽
Volker Diehl
◽
Otto Kloke
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Malignant Melanoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Low Dose
◽
Phase Ii Study
◽
Interleukin 2
Download Full-text
A phase II study of chronic low dose of interleukin-2 (IL-2) and α-interferon (IFN-α) in Metastatic Renal Cell Carcinoma (MRCC)
European Urology Supplements
◽
10.1016/s1569-9056(02)80420-1
◽
2002
◽
Vol 1
(1)
◽
pp. 109
Author(s):
Michele Potenzoni
◽
Luigi Benecchi
◽
Nicoletta Uliano
◽
Federico Cantoni
◽
Matteo Dalla Chiesa
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Low Dose
◽
Phase Ii Study
◽
Interleukin 2
Download Full-text
Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-α, and tegafur-uracil: a single-institution experience
International Journal of Clinical Oncology
◽
10.1007/s10147-007-0752-0
◽
2008
◽
Vol 13
(3)
◽
pp. 257-262
◽
Cited By ~ 3
Author(s):
Minoru Kobayashi
◽
Hitoshi Ikeda
◽
Akinori Nukui
◽
Kazumi Suzuki
◽
Yasuhiro Sugaya
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Clinical Outcome
◽
Cell Carcinoma
◽
Renal Cell
◽
Low Dose
◽
Interleukin 2
◽
Advanced Renal Cell Carcinoma
◽
Interferon Α
◽
Single Institution
◽
Survival Factors
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close